131 related articles for article (PubMed ID: 33385499)
21. Stimulatory effect of pituitary adenylate-cyclase activating polypeptide (PACAP) and its PACAP type I receptor (PAC1R) on prolactin synthesis in rat pituitary somatolactotroph GH3 cells.
Mijiddorj T; Kanasaki H; Purwana IN; Oride A; Miyazaki K
Mol Cell Endocrinol; 2011 Jun; 339(1-2):172-9. PubMed ID: 21539889
[TBL] [Abstract][Full Text] [Related]
22. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin.
Moody TW; Leyton J; Jensen RT
J Mol Neurosci; 2012 Jan; 46(1):68-74. PubMed ID: 21898124
[TBL] [Abstract][Full Text] [Related]
24. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
25. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.
Daub H; Weiss FU; Wallasch C; Ullrich A
Nature; 1996 Feb; 379(6565):557-60. PubMed ID: 8596637
[TBL] [Abstract][Full Text] [Related]
26. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
Cavallaro S; D'Agata V; Guardabasso V; Travali S; Stivala F; Canonico PL
Mol Pharmacol; 1995 Jul; 48(1):56-62. PubMed ID: 7623775
[TBL] [Abstract][Full Text] [Related]
27. The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21(ras) G protein, and pp60(c-src) cytoplasmic tyrosine kinase.
Lazarovici P; Jiang H; Fink D
Mol Pharmacol; 1998 Sep; 54(3):547-58. PubMed ID: 9730914
[TBL] [Abstract][Full Text] [Related]
28. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
El Zein N; Badran B; Sariban E
Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
[TBL] [Abstract][Full Text] [Related]
29. PACAP through EGFR transactivation preserves human corneal endothelial integrity.
Maugeri G; D'Amico AG; Castrogiovanni P; Saccone S; Federico C; Reibaldi M; Russo A; Bonfiglio V; Avitabile T; Longo A; D'Agata V
J Cell Biochem; 2019 Jun; 120(6):10097-10105. PubMed ID: 30548314
[TBL] [Abstract][Full Text] [Related]
30. Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells.
Salazar EP; Hunger-Glaser I; Rozengurt E
J Cell Physiol; 2003 Mar; 194(3):314-24. PubMed ID: 12548551
[TBL] [Abstract][Full Text] [Related]
31. C2-ceramide and reactive oxygen species inhibit pituitary adenylate cyclase activating polypeptide (PACAP)-induced cyclic-AMP-dependent signalling pathway.
Sée V; Koch B; Loeffler JP
J Neurochem; 2001 Feb; 76(3):778-88. PubMed ID: 11158249
[TBL] [Abstract][Full Text] [Related]
32. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
[TBL] [Abstract][Full Text] [Related]
33. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
Drahushuk K; Connell TD; Higgins D
J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
[TBL] [Abstract][Full Text] [Related]
34. Ca2+ signaling through secretagogue and growth factor receptors on pancreatic AR42J cells.
Simeone DM; Yule DI; Logsdon CD; Williams JA
Regul Pept; 1995 Jan; 55(2):197-206. PubMed ID: 7538685
[TBL] [Abstract][Full Text] [Related]
35. PACAP-induced ERK activation in HEK cells expressing PAC1 receptors involves both receptor internalization and PKC signaling.
May V; Buttolph TR; Girard BM; Clason TA; Parsons RL
Am J Physiol Cell Physiol; 2014 Jun; 306(11):C1068-79. PubMed ID: 24696141
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) potentiate the glutamate-evoked release of arachidonic acid from mouse cortical neurons. Evidence for a cAMP-independent mechanism.
Stella N; Magistretti PJ
J Biol Chem; 1996 Sep; 271(39):23705-10. PubMed ID: 8798593
[TBL] [Abstract][Full Text] [Related]
37. The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes.
El Zein N; Corazza F; Sariban E
Cell Signal; 2006 Feb; 18(2):162-73. PubMed ID: 15993038
[TBL] [Abstract][Full Text] [Related]
38. [Pituitary adenylate cyclase-activating polypeptide].
Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
[TBL] [Abstract][Full Text] [Related]
39. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
[TBL] [Abstract][Full Text] [Related]
40. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
